Results for tag: Kenneth Anderson Total Items Found: 10

Newly Diagnosed Multiple Myeloma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 6/25/2021 3:58:45 PM

Bispecific Antibody Platform: Early Data in Relapsed and Refractory Myeloma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 5/10/2021 3:53:57 PM

Anti-BCMA–Directed CAR T-Cell Gene Therapy in Relapsed or Refractory Myeloma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 4/26/2021 3:03:05 PM

Novel Insights Into Multiple Myeloma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 2/10/2021 6:33:38 PM

Novel Therapeutics for Relapsed or Refractory Multiple Myeloma, Part 2

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/18/2019 7:23:54 PM

Novel Treatments in Newly Diagnosed Multiple Myeloma, Part 1

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/18/2019 5:15:50 PM

Daratumumab Plus Bortezomib/Dexamethasone: Changing the Treatment Paradigm in Relapsed or Refractory Myeloma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 10/4/2016 1:00:05 PM

Kenneth Anderson, MD, on Multiple Myeloma Guideline Updates

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 NCCN Annual Meeting
Kenneth Anderson
Dana-Farber Cancer Institute
multiple myeloma

Created: 4/4/2016 2:40:34 PM

Kenneth Anderson MD on Multiple Myeloma Current Treatment Approaches and Future Directions

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
Ken Anderson
Dana Farber
multiple myeloma
lenalidomide
dexamethasone
bortezomib
pomalidomide
panobinostat
ixazomib
elotuzumab
daratumumab

Created: 1/31/2016 9:21:54 AM

Book Excerpt: Family

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 5:07:38 PM
Order By Item Count
Order Alphabetically